{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:03:45Z","timestamp":1786118625558,"version":"build-2736575974"},"reference-count":111,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022TQ0094"],"award-info":[{"award-number":["2022TQ0094"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52372267"],"award-info":[{"award-number":["52372267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20339"],"award-info":[{"award-number":["U20A20339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172582"],"award-info":[{"award-number":["82172582"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20581"],"award-info":[{"award-number":["U23A20581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["FRFCU5710011422"],"award-info":[{"award-number":["FRFCU5710011422"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jpha.2025.101510","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:45:32Z","timestamp":1765212332000},"page":"101510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic repurposing of old drugs to modulate the tumor immune microenvironment and enhance immunotherapy efficacy"],"prefix":"10.1016","volume":"16","author":[{"given":"Yakai","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangcan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2025.101510_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1212476","article-title":"Cancer immunotherapies: advances and bottlenecks","volume":"14","author":"Rui","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101510_bib2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s12026-024-09483-8","article-title":"The immunosuppressive landscape in tumor microenvironment","volume":"72","author":"Liu","year":"2024","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jpha.2025.101510_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpha.2025.101510_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/EDBK_237987","article-title":"Reprogramming the tumor microenvironment to improve immunotherapy: emerging strategies and combination therapies","author":"Datta","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.jpha.2025.101510_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","article-title":"The updated landscape of tumor microenvironment and drug repurposing","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101510_bib6","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.3390\/cells11182894","article-title":"Drepmel: a multi-omics melanoma drug repurposing resource for prioritizing drug combinations and understanding tumor microenvironment","volume":"11","author":"Thompson","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jpha.2025.101510_bib7","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3390\/pharmaceutics15092190","article-title":"Repurposable drugs for immunotherapy and strategies to find candidate drugs","volume":"15","author":"Sakai","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpha.2025.101510_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","article-title":"The future of cancer immunotherapy: microenvironment-targeting combinations","volume":"30","author":"Murciano-Goroff","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jpha.2025.101510_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","article-title":"Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets","volume":"15","author":"Tie","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jpha.2025.101510_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3892\/etm.2020.9528","article-title":"An overview of the tumor microenvironment, from cells to complex networks","volume":"21","author":"Farc","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.jpha.2025.101510_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jpha.2025.101510_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154846","article-title":"Unlocking the potential of the tumor microenvironment for cancer therapy","volume":"251","author":"Tufail","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.jpha.2025.101510_bib13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3390\/pharmaceutics15041143","article-title":"Cancer resistance to immunotherapy: comprehensive insights with future perspectives","volume":"15","author":"Said","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpha.2025.101510_bib14","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jpha.2025.101510_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jpha.2025.101510_bib16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101510_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3892\/ijo.2024.5648","article-title":"Targeting tumor-associated macrophages: critical players in tumor progression and therapeutic strategies","volume":"64","author":"Su","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jpha.2025.101510_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jpha.2025.101510_bib19","series-title":"Indoleamine 2,3-dioxygenase and its Therapeutic Inhibition in Cancer, International Review of Cell and Molecular Biology","first-page":"175","author":"Prendergast","year":"2018"},{"key":"10.1016\/j.jpha.2025.101510_bib20","article-title":"Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101510_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jpha.2025.101510_bib22","first-page":"1527","article-title":"Interferon-\u03b3 and celecoxib inhibit lung-tumor growth through modulating M2\/M1 macrophage ratio in the tumor microenvironment","volume":"8","author":"Ren","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jpha.2025.101510_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6380643","article-title":"Aspirin disrupts the crosstalk of angiogenic and inflammatory cytokines between 4T1 breast cancer cells and macrophages","volume":"2018","author":"Hsieh","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jpha.2025.101510_bib24","doi-asserted-by":"crossref","first-page":"36441","DOI":"10.18632\/oncotarget.5541","article-title":"Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpha.2025.101510_bib25","doi-asserted-by":"crossref","first-page":"20706","DOI":"10.18632\/oncotarget.14982","article-title":"Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-\u03baB signaling","volume":"8","author":"Chiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpha.2025.101510_bib26","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41598-022-05055-8","article-title":"CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor","volume":"12","author":"Chen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2025.101510_bib27","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/s41388-021-02170-0","article-title":"Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment","volume":"41","author":"Fj\u00e6stad","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2025.101510_bib28","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.4049\/jimmunol.1501677","article-title":"Propranolol attenuates surgical stress\u2013induced elevation of the regulatory T cell response in patients undergoing radical mastectomy","volume":"196","author":"Zhou","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.jpha.2025.101510_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1158\/1078-0432.CCR-14-1711","article-title":"Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma","volume":"21","author":"Weed","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib30","article-title":"A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma","volume":"5","author":"Ghosh","year":"2023","journal-title":"Neuro Oncol. Adv."},{"key":"10.1016\/j.jpha.2025.101510_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.21873\/invivo.13078","article-title":"Vitamin D3 supplementation promotes regulatory T-cells to maintain immune homeostasis after surgery for early stages of colorectal cancer","volume":"37","author":"Srichomchey","year":"2023","journal-title":"Vivo"},{"key":"10.1016\/j.jpha.2025.101510_bib32","doi-asserted-by":"crossref","first-page":"16386","DOI":"10.1002\/cam4.6274","article-title":"Low-dose aspirin can inhibit exosomal release induced by radiotherapy in breast cancer and attenuate its inhibitory effect on NK cell proliferation","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.jpha.2025.101510_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jcyt.2015.01.004","article-title":"Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy","volume":"17","author":"Huijskens","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jpha.2025.101510_bib34","doi-asserted-by":"crossref","DOI":"10.5812\/zjrms.94570","article-title":"Combination of propranolol and heated 4T1 cells elicits beneficial response against mouse model of breast cancer","volume":"23","author":"Tavakoli","year":"2021","journal-title":"Zahedan J. Res. Med. Sci."},{"key":"10.1016\/j.jpha.2025.101510_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1995999","article-title":"Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner","volume":"10","author":"Xia","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.jpha.2025.101510_bib36","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1158\/0008-5472.CAN-10-1968","article-title":"IL-2 costimulation enables statin-mediated activation of human NK cells, preferentially through a mechanism involving CD56+ dendritic cells","volume":"70","author":"Gruenbacher","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib37","article-title":"Repurposing pentamidine for cancer immunotherapy by targeting the PD1\/PD-L1 immune checkpoint","volume":"14","author":"Gu","year":"2023","journal-title":"Front\/0. Immunol."},{"key":"10.1016\/j.jpha.2025.101510_bib38","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.eururo.2008.01.013","article-title":"Celecoxib has potent antitumour effects as a single agent and in combination with BCG immunotherapy in a model of urothelial cell carcinoma","volume":"54","author":"Dovedi","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jpha.2025.101510_bib39","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1158\/1078-0432.CCR-17-0895","article-title":"Low-dose cyclophosphamide induces antitumor T-cell responses, which associate with survival in metastatic colorectal cancer","volume":"23","author":"Scurr","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib40","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1158\/1078-0432.CCR-19-3978","article-title":"Evaluation of cyclophosphamide\/GVAX pancreas followed by Listeria-mesothelin (CRS-207) with or without nivolumab in patients with pancreatic cancer","volume":"26","author":"Tsujikawa","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib41","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022110636","article-title":"Disulfiram bolsters T-cell anti-tumor immunity through direct activation of LCK-mediated TCR signaling","volume":"41","author":"Wang","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.jpha.2025.101510_bib42","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720920825","article-title":"Lenalidomide enhances CAR-T cell activity against solid tumor cells","volume":"29","author":"Wang","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.jpha.2025.101510_bib43","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.chembiol.2022.05.012","article-title":"Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling","volume":"29","author":"Geng","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jpha.2025.101510_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-023-06797-9","article-title":"An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis","volume":"625","author":"LaMarche","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101510_bib45","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ccell.2024.03.001","article-title":"Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy","volume":"42","author":"Xue","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jpha.2025.101510_bib46","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1172\/JCI129317","article-title":"Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy","volume":"129","author":"Xu","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jpha.2025.101510_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111321","article-title":"High dose Vitamin C inhibits PD-L1 by ROS-pSTAT3 signal pathway and enhances T cell function in TNBC","volume":"126","author":"Zhao","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jpha.2025.101510_bib48","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1093\/nar\/gkac941","article-title":"Vitamin C enhances NF-\u03baB-driven epigenomic reprogramming and boosts the immunogenic properties of dendritic cells","volume":"50","author":"Morante-Palacios","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2025.101510_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jpha.2025.101510_bib50","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s43018-022-00470-2","article-title":"Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer","volume":"3","author":"Cappellesso","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jpha.2025.101510_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10582","article-title":"Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy","volume":"7","author":"Johnson","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2025.101510_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217432","article-title":"Mechanisms of low MHC I expression and strategies for targeting MHC I with small molecules in cancer immunotherapy","volume":"611","author":"Kong","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jpha.2025.101510_bib53","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1073\/pnas.94.12.6420","article-title":"Expression of Fas ligand in liver metastases of human colonic adenocarcinomas","volume":"94","author":"Shiraki","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpha.2025.101510_bib54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","article-title":"The role of ROS in tumour development and progression","volume":"22","author":"Cheung","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jpha.2025.101510_bib55","first-page":"1587","article-title":"Aspirin-targeted PD-L1 in lung cancer growth inhibition, Thorac","volume":"11","author":"Zhang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jpha.2025.101510_bib56","article-title":"Does the combined use of aspirin and immunotherapy result in better outcomes in non-small cell lung cancer than immunotherapy alone?","volume":"14","author":"Aiad","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jpha.2025.101510_bib57","article-title":"Downregulation of PD-L1 via FKBP5 by celecoxib augments antitumor effects of PD-1 blockade in a malignant glioma model, Neuro Oncol","volume":"2","author":"Yamaguchi","year":"2020","journal-title":"Adv"},{"key":"10.1016\/j.jpha.2025.101510_bib58","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1158\/0008-5472.CAN-18-1781","article-title":"Pomalidomide inhibits PD-L1 induction to promote antitumor immunity","volume":"78","author":"Fujiwara","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2023.02.011","article-title":"Propranolol reduces IFN-\u03b3 driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer","volume":"110","author":"Falcinelli","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jpha.2025.101510_bib60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fimmu.2013.00062","article-title":"Statins reduce melanoma development and metastasis through MICA overexpression","volume":"4","author":"Pich","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpha.2025.101510_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.734853","article-title":"Disulfiram improves the anti-PD-1 therapy efficacy by regulating PD-L1 expression via epigenetically reactivation of IRF7 in triple negative breast cancer","volume":"11","author":"Zheng","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101510_bib62","first-page":"2442","article-title":"Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma","volume":"9","author":"Zhou","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.matbio.2023.04.002","article-title":"Tumor-associated fibrosis impairs the response to immunotherapy","volume":"119","author":"Naik","year":"2023","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jpha.2025.101510_bib64","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2025.101510_bib65","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/ijms17020146","article-title":"Metformin prevents renal fibrosis in mice with unilateral ureteral obstruction and inhibits Ang II-induced ECM production in renal fibroblasts","volume":"17","author":"Shen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2025.101510_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141392","article-title":"Metformin reduces desmoplasia in pancreatic cancer by reprogramming stellate cells and tumor-associated macrophages","volume":"10","author":"Incio","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101510_bib67","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1476-5381.2010.00762.x","volume":"160","author":"Hwang","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2025.101510_bib68","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.semcancer.2020.05.018","article-title":"An update on vitamin D signaling and cancer","volume":"79","author":"Carlberg","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jpha.2025.101510_bib69","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1136\/gutjnl-2015-310977","article-title":"Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer","volume":"66","author":"Ferrer-Mayorga","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jpha.2025.101510_bib70","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/gutjnl-2018-316627","article-title":"VDR signaling inhibits cancer-associated-fibroblasts\u2019 release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells","volume":"68","author":"Kong","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jpha.2025.101510_bib71","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jpha.2025.101510_bib72","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/cancers13040904","article-title":"Metabolism of innate immune cells in cancer","volume":"13","author":"Talty","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jpha.2025.101510_bib73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2018.04.022","article-title":"Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB isoform in triple-negative breast cancer","volume":"28","author":"Li","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.jpha.2025.101510_bib74","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.jpha.2025.101510_bib75","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1158\/1541-7786.MCR-19-0517","article-title":"Glutamine deprivation induces PD-L1 expression via activation of EGFR\/ERK\/c-Jun signaling in renal cancer","volume":"18","author":"Ma","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib76","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.jpha.2025.101510_bib77","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2025.101510_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112945","article-title":"HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.jpha.2025.101510_bib79","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-020-0376-4","article-title":"Targeting CD39 in cancer","volume":"20","author":"Moesta","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jpha.2025.101510_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110350","article-title":"Aspirin induces immunogenic cell death and enhances cancer immunotherapy in colorectal cancer","volume":"121","author":"Lei","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jpha.2025.101510_bib81","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/0008-5472.CAN-24-1611","article-title":"Targeting arachidonic acid metabolism enhances immunotherapy efficacy in ARID1A-deficient colorectal cancer","volume":"85","author":"Cui","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib82","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jconrel.2024.05.002","article-title":"Orally available dextran-aspirin nanomedicine modulates gut inflammation and microbiota homeostasis for primary colorectal cancer therapy","volume":"370","author":"Ma","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jpha.2025.101510_bib83","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-22-3042","article-title":"Metformin reprograms tryptophan metabolism to stimulate CD8+ T-cell function in colorectal cancer","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib84","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/antiox12030632","article-title":"Antioxidant and anti-tumor effects of dietary vitamins A, C, and E","volume":"12","author":"Didier","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.jpha.2025.101510_bib85","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13046-021-02134-y","article-title":"High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer","volume":"40","author":"B\u00f6ttger","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib86","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/carcin\/bgv123","article-title":"Immunosuppression associated with chronic inflammation in the tumor microenvironment","volume":"36","author":"Wang","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jpha.2025.101510_bib87","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1073\/pnas.1804000116","article-title":"Aspirin-triggered proresolving mediators stimulate resolution in cancer","volume":"116","author":"Gilligan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpha.2025.101510_bib88","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41467-020-14338-5","article-title":"Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties","volume":"11","author":"Terashima","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2025.101510_bib89","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1002\/cam4.3346","article-title":"Intestinal microbiota regulates anti-tumor effect of disulfiram combined with Cu2+ in a mice model","volume":"9","author":"Hu","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.jpha.2025.101510_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.602817","article-title":"Beyond TNBC: repositioning of clofazimine against a broad range of wnt-dependent cancers","volume":"10","author":"Xu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpha.2025.101510_bib91","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3324\/haematol.2018.194910","article-title":"Leprosy drug clofazimine activates peroxisome proliferator-activated receptor-\u03b3 and synergizes with imatinib to inhibit chronic myeloid leukemia cells","volume":"105","author":"Kumar","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jpha.2025.101510_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004009","article-title":"Clofazimine inhibits human Kv1.3 potassium channel by perturbing calcium oscillation in T lymphocytes","volume":"3","author":"Ren","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jpha.2025.101510_bib93","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12967-025-06293-w","article-title":"Repurposing the anti-parasitic agent pentamidine for cancer therapy; a novel approach with promising anti-tumor properties","volume":"23","author":"Rastegar-Pouyani","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jpha.2025.101510_bib94","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1111\/jcmm.14943","article-title":"Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue","volume":"24","author":"Seguella","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jpha.2025.101510_bib95","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1111\/j.1365-2567.2008.02954.x","article-title":"Hypoxia skews dendritic cells to a T helper type 2-stimulating phenotype and promotes tumour cell migration by dendritic cell-derived osteopontin","volume":"128","author":"Yang","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jpha.2025.101510_bib96","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-01-065714","article-title":"Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF","volume":"110","author":"Huang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jpha.2025.101510_bib97","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2025.101510_bib98","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12032-022-01898-3","article-title":"The effect of dual-frequency sonication in the presence of thalidomide angiogenesis inhibitor and nanomicelles containing doxorubicin on inhibiting the growth and angiogenesis of breast adenocarcinoma in vivo","volume":"40","author":"Goleh","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jpha.2025.101510_bib99","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.biopha.2012.04.005","article-title":"Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice","volume":"66","author":"Maria de Souza","year":"2012","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jpha.2025.101510_bib100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s13046-019-1366-x","article-title":"Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin","volume":"38","author":"Shen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jpha.2025.101510_bib101","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1111\/jcmm.13655","article-title":"Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jpha.2025.101510_bib102","doi-asserted-by":"crossref","DOI":"10.1177\/20503121211001641","article-title":"Metformin: the next angiogenesis Panacea?","volume":"9","author":"Ren","year":"2021","journal-title":"SAGE Open Med."},{"key":"10.1016\/j.jpha.2025.101510_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5524","article-title":"Drug repurposing: misconceptions, challenges, and opportunities for academic researchers","volume":"13","author":"Begley","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jpha.2025.101510_bib104","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101510_bib105","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010928","article-title":"Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols","volume":"13","author":"Cottrell","year":"2025","journal-title":"J. ImmunoTherapy Cancer"},{"key":"10.1016\/j.jpha.2025.101510_bib106","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jpha.2025.101510_bib107","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","article-title":"Spatial profiling technologies illuminate the tumor microenvironment","volume":"41","author":"Elhanani","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jpha.2025.101510_bib108","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/2159-8290.CD-23-1199","article-title":"Artificial intelligence in oncology: current landscape, challenges, and future directions","volume":"14","author":"Lotter","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jpha.2025.101510_bib109","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jconrel.2021.01.009","article-title":"The right Timing, right combination, right sequence, and right delivery for cancer immunotherapy","volume":"331","author":"Kwon","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jpha.2025.101510_bib110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41392-024-01760-0","article-title":"New clinical trial design in precision medicine: discovery, development and direction","volume":"9","author":"Duan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2025.101510_bib111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1513749","article-title":"Adaptive randomization of veliparib\u2013carboplatin treatment in breast cancer","volume":"375","author":"Rugo","year":"2016","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925003272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177925003272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:18:39Z","timestamp":1786033119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177925003272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":111,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2095177925003272"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101510","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic repurposing of old drugs to modulate the tumor immune microenvironment and enhance immunotherapy efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2025.101510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101510"}}